Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

EVAN MICHAEL LAPINSKY

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1134486046
CMS profile
2153611
Location
NEWARK, DE

General Payments · PY2020–2024

$897.43

  • Reported across 49 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$283.86

12 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $283.86 12

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $317.03 21
PY2021 $94.49 6
PY2022 $87.99 4
PY2023 $114.06 6
PY2024 $283.86 12

Payment records · PY2024 (12)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $20.54 11/06/2024 Food and Beverage Undisputed 01/23/2026 1139426281 CMS
AstraZeneca Pharmaceuticals LP $20.96 04/09/2024 Food and Beverage Undisputed 01/23/2026 1105680127 CMS
AstraZeneca Pharmaceuticals LP $13.74 10/16/2024 Food and Beverage Undisputed 01/23/2026 1105832609 CMS
Celgene Corporation $38.47 12/11/2024 Food and Beverage Undisputed 01/23/2026 1101110952 CMS
Genmab U.S., Inc. $33.59 07/31/2024 Food and Beverage Undisputed 01/23/2026 1126826488 CMS
Gilead Sciences, Inc. $23.92 04/16/2024 Food and Beverage Undisputed 01/23/2026 1133795177 CMS
Incyte Corporation $25.52 07/10/2024 Food and Beverage Undisputed 01/23/2026 1141275616 CMS
Merck Sharp & Dohme LLC $14.93 07/03/2024 Food and Beverage Undisputed 01/23/2026 1141737999 CMS
Novartis Pharmaceuticals Corporation $22.51 05/01/2024 Food and Beverage Undisputed 01/23/2026 1087140642 CMS
Novartis Pharmaceuticals Corporation $31.12 05/01/2024 Food and Beverage Undisputed 01/23/2026 1087140652 CMS
PFIZER INC. $18.35 09/04/2024 Food and Beverage Undisputed 01/23/2026 1131339128 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.21 12/04/2024 Food and Beverage Undisputed 01/23/2026 1144961424 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.